Related Experiment Video
Updated: Apr 14, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Understanding the molecular basis of EGFR kinase domain/MIG-6 peptide recognition complex using computational
Ninnutt Moonrin1, Napat Songtawee2, Siriluk Rattanabunyong3
1Department of Biochemistry, Faculty of Science, Kasetsart University, 50 Ngam, Wong Wan Rd, Bangkok, Chatuchak, 10900, Thailand. moonrin_jear@hotmail.com.
Background:
Epidermal growth factor receptor (EGFR) signalling plays a major role in biological processes, including cell proliferation, differentiation and survival. Since the over-expression of EGFR causes human cancers, EGFR is an attractive drug target. A tumor suppressor endogenous protein, MIG-6, is known to suppress EGFR over-expression by binding to the C-lobe of EGFR kinase. Thus, this C-lobe of the EGFR kinase is a potential new target for EGFR kinase activity inhibition. In this study, molecular dynamics (MD) simulations and binding free energy calculations were used to investigate the protein-peptide interactions between EGFR kinase and a 27-residue peptide derived from MIG-6_s1 segment (residues 336-362).
Results:
These 27 residues of MIG-6_s1 were modeled from the published MIG-6 X-ray structure. The binding dynamics were detailed by applying the molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) method to predict the binding free energy. Both van der Waals interactions and non-polar solvation were favorable driving forces for binding process. Six residues of EGFR kinase and eight residues of MIG-6_s1 residues were shown to be responsible for interface binding in which we investigated per residue free energy decomposition and the results from the computational alanine scanning approach. These residues also had higher hydrogen bond occupancies than other residues at the binding interface. The results from the aforementioned calculations reasonably agreed with the previous experimental mutagenesis studies.
Conclusions:
Molecular dynamics simulations were used to investigate the interactions of MIG-6_s1 to EGFR kinase domain. Our study provides an insight into such interactions that is useful in guiding the design of novel anticancer therapeutics. The information on our modelled peptide interface with EGFR kinase could be a possible candidate for an EGFR dimerization inhibitor.
Insights
Molecular dynamics simulations reveal how MIG-6 peptide binds to EGFR kinase, identifying key residues for interaction. This finding aids in designing new EGFR inhibitors for cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Computational Chemistry
Background:
- Epidermal growth factor receptor (EGFR) signaling is crucial for cell functions.
- EGFR overexpression drives human cancers, making it a key drug target.
- MIG-6 protein suppresses EGFR by binding to its kinase domain.
Purpose of the Study:
- Investigate protein-peptide interactions between EGFR kinase and a MIG-6 derived peptide.
- Identify key residues and forces driving the binding interaction.
- Provide insights for designing novel EGFR kinase inhibitors.
Main Methods:
- Molecular dynamics (MD) simulations.
- Binding free energy calculations using MM-PBSA.
- Computational alanine scanning for residue analysis.
Main Results:
- Identified six EGFR and eight MIG-6 residues critical for binding interface.
- Van der Waals and non-polar solvation are favorable binding forces.
- Calculations align with previous experimental mutagenesis studies.
Conclusions:
- MD simulations elucidated MIG-6 peptide interactions with EGFR kinase.
- Findings guide the design of novel anticancer therapeutics targeting EGFR.
- The studied peptide interface may serve as an EGFR dimerization inhibitor.
More Related Videos
09:16Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy
Published on: September 11, 2015
06:50Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024